You just read:

Genprex Reports New Pre-Clinical Data Showing Strong Anti-Tumor Effect Of TUSC2 In Combination With PD-1 Checkpoint Blockade In Lung Cancer

News provided by

Genprex, Inc.

Apr 02, 2017, 13:00 ET